Filing metadata

Accession number
0001445826-26-000015
Form type
Form 4
Filer
Agomab Therapeutics NV
CIK
CIK 2020932
Filed
Oct 22, 2026
Reporting period
Oct 21, 2026
Description
Insider transaction

Explore SEC Filings Hub